Literature DB >> 19340672

Gestational age at enrollment and continued substance use among pregnant women in drug treatment.

Mishka Terplan1, Joanne Garrett, Katherine Hartmann.   

Abstract

Substance use during pregnancy is associated with poor obstetrical and neonatal outcomes. Although intervention for substance use including alcohol improves pregnancy outcomes, a substantial number of women continue to use drugs or consume alcohol during treatment. To determine whether gestational age at entry into treatment (specifically first trimester enrollment) was associated with lower risk of continued substance use, we analyzed the North Carolina Treatment Outcomes and Program Performance System, an administrative database of drug treatment clinics, between 2000 and 2004. There were 847 pregnant women using substances who met our inclusion criteria. Demographic and other risk factor data were collected. We conducted logistic regression and a Generalized Estimating Equation analysis. Gestational age at enrollment was not associated with continued substance use (odds ratio [OR] = 0.88; 95% confidence interval [CI] = 0.51, 1.51). Women who had child care provided, were less likely to continue substance use (OR = 0.64; 95% CI = 0.48, 0.84), whereas those referred from the criminal justice system were more likely to continue (OR = 1.53; 95% CI = 1.01, 2.30). Although earlier gestational age at enrollment in treatment does not predict greater abstinence at any time point, this data does suggest that the provision of childcare may improve treatment success.

Entities:  

Mesh:

Year:  2009        PMID: 19340672      PMCID: PMC3869395          DOI: 10.1080/10550880902772399

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  36 in total

Review 1.  The effects of maternal cocaine abuse on mothers and newborns.

Authors:  K Kaltenbach
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Maternal drug use during pregnancy: are preterm and full-term infants affected differently?

Authors:  J V Brown; R Bakeman; C D Coles; W R Sexson; A S Demi
Journal:  Dev Psychol       Date:  1998-05

3.  Women's programs versus mixed-gender day treatment: results from a randomized study.

Authors:  Lee Ann Kaskutas; Lixia Zhang; Michael T French; Jane Witbrodt
Journal:  Addiction       Date:  2005-01       Impact factor: 6.526

4.  Factors affecting substance abuse treatment completion for women.

Authors:  P J Kelly; B Blacksin; E Mason
Journal:  Issues Ment Health Nurs       Date:  2001 Apr-May       Impact factor: 1.835

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Three-year developmental outcomes in children with prenatal alcohol and drug exposure.

Authors:  Deborah Kartin; Therese M Grant; Ann P Streissguth; Paul D Sampson; Cara C Ernst
Journal:  Pediatr Phys Ther       Date:  2002       Impact factor: 3.049

7.  Drug-exposed infants. American Academy of Pediatrics Committee on Substance Abuse.

Authors: 
Journal:  Pediatrics       Date:  1995-08       Impact factor: 7.124

8.  Cocaine abuse during pregnancy: correlation between prenatal care and perinatal outcome.

Authors:  S N MacGregor; L G Keith; J A Bachicha; I J Chasnoff
Journal:  Obstet Gynecol       Date:  1989-12       Impact factor: 7.661

9.  Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report.

Authors:  Theresa M Winhusen; Eugene C Somoza; Bonita Singal; Sunme Kim; Paul S Horn; John Rotrosen
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

10.  Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse.

Authors:  Joanne P Ludlow; Sharon F Evans; Gary Hulse
Journal:  Aust N Z J Obstet Gynaecol       Date:  2004-08       Impact factor: 2.100

View more
  1 in total

1.  State Policies Targeting Alcohol Use during Pregnancy and Alcohol Use among Pregnant Women 1985-2016: Evidence from the Behavioral Risk Factor Surveillance System.

Authors:  Sarah C M Roberts; Amy A Mericle; Meenakshi S Subbaraman; Sue Thomas; Ryan D Treffers; Kevin L Delucchi; William C Kerr
Journal:  Womens Health Issues       Date:  2019-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.